David Deems

Xceed Molecular Corporation is a molecular diagnostic company dedicated to commercializing a platform for automated gene expression analysis and developing proprietary clinical research assays and custom arrays. They develop tools and content aimed at accelerating the current market trend towards 'translational medicine', and bridging the gap from gene signature validation to clinical diagnostics. The Ziplex Automated Workstation is the first integrated and fully automated hybridization system for multiplex gene expression signatures. Their integrated solution - the Ziplex System - features this innovative instrument platform and focused-content TipChip arrays and reagents to perform highly multiplexed molecular assays with superior accuracy, reproducibility, speed and scalability. The Ziplex System is designed to provide the ease-of-use in assay automation and analytics that is required to successfully translate gene expression analysis from research use into routine practice. Xceed complements the Ziplex platform by offering Gene Expression Services and Assay Development Services.

Cellaria Biosciences LLC engages in research and development of cancer cure products. The firm offers cancer research custom and stem cell services. The company is headquartered in Wakefield, MA.

Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada.

Cephos Corp. develops biotechnology products. The private company is based in Pepperell, MA.

BD Biosciences, Systems & Reagents, Inc. provides tools and solutions to research and clinical laboratories in basic research, drug discovery, development, biopharmaceutical production and disease management. The company was founded on May 9, 1991 and is headquartered in San Jose, CA.

Part of Harvard Bioscience, Inc., FKAUBI, Inc. is a company that specializes in Union Biometrica publications and UnionBio Applications. The company is based in Somerville, MA. The company offers an introduction to Large Object Flow Cytometry. FKAUBI was acquired by Harvard Bioscience, Inc. on May 31, 2001 for $13.37 million.

Predicant Biosciences, Inc. is a life sciences company, which used to develop minimally invasive technology for identifying and assaying protein biomarker patterns that reflect and differentiate biological states. It was founded in 2002 and was located in San Francisco, CA